Upcoming HERA call under EU4Health – Rapid point-of-care antimicrobial susceptibility testing diagnostic medical device

The European Health Emergency Preparedness and Response Authority (HERA) has announced a new call for proposals under the EU4Health program, aimed at enhancing Europe’s preparedness against health threats. This funding opportunity focuses on rapid antimicrobial susceptibility testing diagnostics. With a significant budget allocation, this initiative seeks to foster innovation in medical countermeasures, strengthen public health strategies, and ensure faster responses to emerging health crises.
Researchers, biotech firms, and healthcare stakeholders are encouraged to submit their proposals before the deadline.
Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device
Scope: This call for tenders seeks to accelerate the development of rapid point-of-care diagnostic devices providing antimicrobial susceptibility results within one hour, ideally with pathogen identification, targeting priority bacterial and fungal pathogens, progressing from TRL 3+ towards CE marking and TRL 8 qualification. This is a competitive procedure with negotiation with a maximum contract duration of 48 months.
Deadline for receipt of requests to participate: 12.5.2025 16:00 Europe/Brussels
Estimated total value: EUR 12.86Mio
Read more: PoC AMR/AST Diagnostic Device F&Ts Application Webpage
Source: Business Finland
Image: Polina Tankilevitch